Perception of COVID-19 vaccines in rheumatology patients.

Simple item page
dc.contributor.authorRomero Bogado, Liz
dc.contributor.authorSteiner, Martina
dc.contributor.authorAndreu Vázquez, Cristina
dc.contributor.authorThuissard Vasallo, Israel John
dc.contributor.authorCobo Ibáñez, María Tatiana
dc.contributor.authorCámara Fernández, Isabel de la
dc.contributor.authorEsteban Vázquez, Ana
dc.contributor.authorParedes Romero, María Beatriz
dc.contributor.authorRichi Alberti, Patricia
dc.contributor.authorTrives Folguera, Laura
dc.contributor.authorVergara Dangond, Cristina
dc.contributor.authorCastañeda, Elisabet
dc.contributor.authorAcosta Alfaro, Ana
dc.contributor.authorCueva Nájera, Gabriela
dc.contributor.authorSánchez Díaz, Rosa
dc.contributor.authorPuerto Muñoz, Encarnación
dc.contributor.authorMuñoz Fernández, Santiago
dc.date.accessioned2026-02-17T15:17:51Z
dc.date.available2026-02-17T15:17:51Z
dc.date.issued2025
dc.description.abstractSince the development of vaccines for coronavirus disease 2019 (COVID-19), the course of infections has changed significantly. Over the past 4 years of coexisting with the virus, a marked improvement in disease outcomes has been observed, especially in patients with rheumatological diseases; this is largely attributable to widespread immunization. This study aimed to evaluate the perception of COVID-19 vaccine protection and to describe the incidence and severity of COVID-19 in the pre- and post-vaccination periods among different patient typologies and immunosuppressive treatments in rheumatology patients. This study used observational, descriptive–analytical, ambispective, and cross-sectional methods.en
dc.description.filiationUEMspa
dc.description.impact1.4 Q2 JCR 2024
dc.description.impact0.469 Q3 SJR 2024
dc.description.impactNo data IDR 2024
dc.description.sponsorshipFundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Sofía y Hospital Universitario del Henares FHH20/COVID07es
dc.identifier.citationRomero-Bogado, L., Steiner, M., Andreu-Vázquez, C., Thuissard-Vasallo, I. J., Cobo-Ibáñez, T., De La Cámara-Fernández, I., Esteban-Vázquez, A., Paredes-Romero, M. B., Richi-Alberti, P., Trives-Folguera, L., Vergara-Dangond, C., Castañeda, E., Acosta-Alfaro, A. V., Cueva-Nájera, G., Sánchez-Díaz, R., Puerto-Muñoz, E., & Muñoz-Fernández, S. (2025). Perception of COVID-19 vaccines in rheumatology patients. Medicine, 104(31), e43618. https://doi.org/10.1097/MD.0000000000043618
dc.identifier.doi10.1097/MD.0000000000043618
dc.identifier.issn0025-7974
dc.identifier.issn1536-5964
dc.identifier.urihttps://hdl.handle.net/11268/16822
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1097/MD.0000000000043618
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.otherCOVID-19
dc.subject.otherVacunas contra la COVID-19
dc.subject.otherAntirreumáticos
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoPandemia
dc.subject.unescoVacunación
dc.subject.unescoInvestigación médica
dc.titlePerception of COVID-19 vaccines in rheumatology patients.
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication96441163-8faa-4570-a1b0-c26c2f41d397
relation.isAuthorOfPublication6ec266f2-8e29-4c5c-be70-5f0a58f67db8
relation.isAuthorOfPublicationd2fd2866-7549-4771-ab4e-efc5d0c36e24
relation.isAuthorOfPublicationaf8b4da6-c0e8-459a-8f7f-8b365df94d3b
relation.isAuthorOfPublication.latestForDiscovery96441163-8faa-4570-a1b0-c26c2f41d397

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Perception of COVID-19_2025
Size:
720.05 KB
Format:
Adobe Portable Document Format
Download

Collections

Área de Ciencias de la Salud